Who owns AARDVARK THERAPEUTICS INC?
- Ticker: AARD
- CUSIP Number: 002942100
Tip: Access positions for across all investors
Analyze quarterly positions in Aardvark Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aardvark Therapeutics stock
Who bought or sold AARDVARK THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Decheng Capital | 3.9M | $15M | 0% | Mar 2026 |
|
| Citadel Advisors | 1.3M | $4.9M | 0% | Mar 2026 |
|
| Laurion Capital Management | 1.0M | $13M | -3% | Dec 2025 |
|
| BlackRock | 793k | $3.0M | 1% | Mar 2026 |
|
| Vanguard Group | 717k | $9.4M | 29% | Dec 2025 |
|
| Vanguard Capital Management | 554k | $2.1M | 100% | Mar 2026 |
|
| Polygon Management | 317k | $1.2M | 100% | Mar 2026 |
|
| Geode Capital Management | 309k | $1.2M | 4% | Mar 2026 |
|
| Silverarc Capital Management | 304k | $4.0M | -1% | Dec 2025 |
|
| Two Sigma Investments | 163k | $616k | 27% | Mar 2026 |
|
| State Street Corporation | 158k | $2.1M | 70% | Dec 2025 |
|
| UBS Group | 158k | $595k | 488% | Mar 2026 |
|
| AQR Capital Management | 135k | $511k | 100% | Mar 2026 |
|
| Millennium Management | 98k | $371k | -80% | Mar 2026 |
|
| Northern Trust | 89k | $1.2M | 56% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 83k | $314k | 100% | Mar 2026 |
|
| Vanguard Portfolio Management | 75k | $283k | 100% | Mar 2026 |
|
| Woodline Partners | 72k | $273k | 100% | Mar 2026 |
|
| Superstring Capital Management | 70k | $912k | 100% | Dec 2025 |
|
| Cantor Fitzgerald, L. P. | 67k | $251k | -27% | Mar 2026 |
|
| Citigroup | 46k | $174k | 100% | Mar 2026 |
|
| Cresset Asset Management | 43k | $163k | 100% | Mar 2026 |
|
| Jump Financial | 35k | $454k | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 32k | $414k | 121% | Dec 2025 |
|
| Bank of New York Mellon | 29k | $111k | 31% | Mar 2026 |
|
| GSA Capital Partners | 27k | $102k | -25% | Mar 2026 |
|
| Bridgeway Capital Management | 27k | $354k | 23% | Dec 2025 |
|
| XTX Topco | 26k | $335k | 100% | Dec 2025 |
|
| Centiva Capital | 25k | $93k | -75% | Mar 2026 |
|
| Barclays | 21k | $269k | -49% | Dec 2025 |
|
| Jane Street | 20k | $75k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 19k | $73k | -64% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 18k | $68k | 180% | Mar 2026 |
|
| ALPS Advisors | 18k | $67k | -1% | Mar 2026 |
|
| Morgan Stanley | 18k | $66k | 100% | Mar 2026 |
|
| Diadema Partners | 16k | $209k | 100% | Dec 2025 |
|
| Nuveen | 15k | $58k | -63% | Mar 2026 |
|
| Bank of America Corporation | 12k | $43k | 100% | Mar 2026 |
|
| MetLife Investment Advisors | 7.8k | $102k | 100% | Dec 2025 |
|
| Rhumbline Advisers | 6.7k | $25k | -12% | Mar 2026 |
|
| Mirae Asset Global Etfs Holdings | 6.1k | $23k | 2% | Mar 2026 |
|
| Vanguard Global Advisers | 5.9k | $22k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 4.7k | $18k | -67% | Mar 2026 |
|
| Steward Partners Investment Advisory | 4.2k | $16k | 100% | Mar 2026 |
|
| China Universal Asset Management | 3.9k | $15k | 9% | Mar 2026 |
|
| New York State Common Retirement Fund | 3.8k | $14k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 3.2k | $12k | -80% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 2.1k | $8.0k | 0% | Mar 2026 |
|
| FMR | 1.3k | $17k | 246% | Dec 2025 |
|
| Legal & General Group | 1.1k | $4.3k | -11% | Mar 2026 |
|
| Mirae Asset Global Investments | 1.1k | $4.3k | 7% | Mar 2026 |
|
| Federated Investors | 1.1k | $4.1k | 100% | Mar 2026 |
|
| Essential Partners | 1.1k | $4.0k | 100% | Mar 2026 |
|
| Stone House Investment Management | 1.0k | $3.8k | 0% | Mar 2026 |
|
| Tower Research Capital | 811.00 | $11k | -32% | Dec 2025 |
|
| California State Teachers Retirement System | 689.00 | $2.6k | -12% | Mar 2026 |
|
| Summit Investment Advisors | 578.00 | $2.2k | 0% | Mar 2026 |
|
| Larson Financial Group | 506.00 | $6.6k | 100% | Dec 2025 |
|
| Gf Fund Management | 483.00 | $1.8k | 13% | Mar 2026 |
|
| Russell Investments | 469.00 | $1.8k | 0% | Mar 2026 |
|
| Hilton Head Capital Partners | 434.00 | $1.6k | 100% | Mar 2026 |
|
| EverSource Wealth Advisors | 301.00 | $1.1k | 402% | Mar 2026 |
|
| MAI Wealth Advisors | 276.00 | $1.0k | 100% | Mar 2026 |
|
| Sterling Capital Management | 233.00 | $877.990600 | -32% | Mar 2026 |
|
| Royal Bank of Canada | 180.00 | $0 | -41% | Mar 2026 |
|
| Rothschild Investment | 77.00 | $289.997400 | 100% | Mar 2026 |
|
| True Wealth Design | 49.00 | $184.999500 | 100% | Mar 2026 |
|
| Wealth Preservation Advisors | 31.00 | $117.000200 | 100% | Mar 2026 |
|
| Farther Finance Advisors | 28.00 | $114.998800 | 100% | Mar 2026 |
|
| Pnc Financial Services | 28.00 | $105.999600 | 100% | Mar 2026 |
|
| SRS Capital Advisors | 24.00 | $22.999200 | 100% | Mar 2026 |
|
| IFP Advisors | 21.00 | $78.999900 | 100% | Mar 2026 |
|
| Harbour Investments | 20.00 | $78.000000 | 100% | Mar 2026 |
|
| CWM | 17.00 | $0 | 13% | Dec 2025 |
|
| Transamerica Financial Advisors | 14.00 | $52.000200 | 100% | Mar 2026 |
|
| Sunbelt Securities | 4.00 | $15.000000 | 100% | Mar 2026 |
|
| SJS Investment Consulting | 2.00 | $8.000000 | 100% | Mar 2026 |
|
Who sold out of Aardvark Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Adage Capital Partners GP | Sep 2025 | 350k | $4.7M |
| Schonfeld Strategic Advisors | Dec 2025 | 50k | $658k |
| Propel Bio Management | Dec 2025 | 46k | $609k |
| Point72 Asset Management | Dec 2025 | 37k | $485k |
| Hrt Financial | Dec 2025 | 31k | $407k |
| Two Sigma Advisers | Dec 2025 | 26k | $344k |
| Thomas Stevens, CFA" | Dec 2025 | 21k | $218k |
| Diametric Capital | Dec 2025 | 19k | $253k |
| Trexquant Investment | Dec 2025 | 17k | $221k |
| Walleye Trading Advisors | Dec 2025 | 16k | $211k |
| Balyasny Asset Management | Dec 2025 | 14k | $181k |
| Persistent Asset Partners | Dec 2025 | 4.2k | $56k |
| Jpmorgan Chase & Co | Sep 2025 | 2.3k | $31k |
| Amalgamated Bank | Dec 2025 | 400.00 | $5.0k |